Promimic AB (OSTO:PRO) 5-Year EBITDA Growth Rate: 34.10% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PRO Promimic AB OSTO:PRO
68 GF Score
Price kr9.85
GF Value kr32.32
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Promimic AB 5-Year EBITDA Growth Rate?

Promimic AB OSTO:PRO -0.51% 68 5-Year EBITDA Growth Rate is 34.10% as of Mar. 2026. GuruFocus rates OSTO:PRO with a GF Score™ of 68/100 and a GF Value™ of kr32.32 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Promimic AB's EBITDA per Share for the three months ended in Mar. 2026 was kr-0.10.

During the past 3 years, the average EBITDA Per Share Growth Rate was 47.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 34.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Promimic AB was 47.50% per year. The lowest was -9.90% per year. And the median was 35.05% per year.


Promimic AB  (OSTO:PRO) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Promimic AB 5-Year EBITDA Growth Rate Related Terms


OSTO:PRO vs ABT, SYK, MDT: 5-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Promimic AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promimic AB 5-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Promimic AB's 5-Year EBITDA Growth Rate falls into.


OSTO:PRO
68GF Score
Promimic AB OSTO:PRO
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Promimic AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 34.10% mean?
Promimic AB (OSTO:PRO) has a 5-Year EBITDA Growth Rate of 34.10% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Promimic AB and its competitors.
Is Promimic AB's 5-Year EBITDA Growth Rate too high?
Promimic AB's current 5-Year EBITDA Growth Rate is 34.10%. Overall, Promimic AB has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Promimic AB's 5-Year EBITDA Growth Rate compare to ABT and SYK?
Promimic AB's 5-Year EBITDA Growth Rate of 34.10% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
A good 5-Year EBITDA Growth Rate depends on the Medical Devices & Instruments industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Promimic AB and its competitors. Promimic AB's current 5-Year EBITDA Growth Rate is 34.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promimic AB stock overvalued right now?
Based on GuruFocus' analysis, Promimic AB (OSTO:PRO) is currently considered Significantly Undervalued. The stock's GF Value™ is kr32.32, compared to a current price of kr9.85 — trading 69.5% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 34.10%. Promimic AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Promimic AB (OSTO:PRO), the current 5-Year EBITDA Growth Rate is 34.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Promimic AB (OSTO:PRO) Overvalued in 2026?

Based on GuruFocus' analysis, Promimic AB stock appears to be undervalued. The current stock price of kr9.85 is trading 69.5% below its estimated GF Value™ of kr32.32. GuruFocus considers Promimic AB to be Significantly Undervalued.

Key valuation signals for OSTO:PRO:

  • 5-Year EBITDA Growth Rate: 34.10%
  • GF Value™: kr32.32 vs. price of kr9.85 (69.5% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the OSTO:PRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Promimic AB Business Description

Address care of AstraZeneca Research and Development Molndal, AZ BioVentureHub, Molndal, SWE, 431 83
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.
68GF Score

Get the complete analysis for OSTO:PRO

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.85
Price
kr32.32
GF Value